Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Devillier

Showing results (61-70 of 147) with videos related to

Pageof 15
Sort By:
Revue Des Maladies Respiratoires|November 29, 2016
Pharmacological treatment optimization for stable chronic obstructive pulmonary disease. Proposals from the Société de Pneumologie de Langue FrançaiseM Zysman, F Chabot, P Devillier, et al.
British Journal of Pharmacology|June 5, 2015
15-Lipoxygenases regulate the production of chemokines in human lung macrophagesC Abrial, S Grassin-Delyle, H Salvator, et al.
Revue De Pneumologie Clinique|September 17, 2011
[Obesity, poor prognostic factor in pandemic influenza A (H1N1) 2009: the role of adipokines in the modulation of respiratory defenses]H Salvator, P Devillier, E Rivaud, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1992
Activation of an epithelial neurokinin NK-1 receptor induces relaxation of rat trachea through release of prostaglandin E2P Devillier, G M Acker, C Advenier, et al.
Revue Des Maladies Respiratoires|November 14, 2014
[A new fixed dose combination of fluticasone and formoterol in a pressurised metered-dose inhaler for the treatment of asthma]P Devillier, H Salvator, S Grassin-Delyle, et al.
Allergy|July 25, 2014
House dust mite sublingual immunotherapy is safe and appears to be effective in moderate, persistent asthmaL Wang, J Yin, R Fadel, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 8, 2010
Pharmacological characterization of olodaterol, a novel inhaled beta2-adrenoceptor agonist exerting a 24-hour-long duration of action in preclinical modelsT Bouyssou, P Casarosa, E Naline, et al.
Cardiovascular Research|December 21, 2000
Cysteinyl leukotrienes are involved in angiotensin II-induced contraction of aorta from spontaneously hypertensive ratsF Stanke-Labesque, P Devillier, S Veitl, et al.
British Journal of Clinical Pharmacology|December 23, 1998
Frusemide inhibits angiotensin II-induced contraction on human vascular smooth muscleF Stanke, P Devillier, D Bréant, et al.
Fundamental & Clinical Pharmacology|January 1, 1997
Pharmacokinetics of intrarectal nalbuphine in children undergoing general anaesthesiaG Bessard, J P Alibeu, M Cartal, et al.
Pageof 15

Showing results (61-70 of 147) with videos related to

Sort By:
Pageof 15
Revue Des Maladies Respiratoires|November 29, 2016
Pharmacological treatment optimization for stable chronic obstructive pulmonary disease. Proposals from the Société de Pneumologie de Langue FrançaiseM Zysman, F Chabot, P Devillier, et al.
British Journal of Pharmacology|June 5, 2015
15-Lipoxygenases regulate the production of chemokines in human lung macrophagesC Abrial, S Grassin-Delyle, H Salvator, et al.
Revue De Pneumologie Clinique|September 17, 2011
[Obesity, poor prognostic factor in pandemic influenza A (H1N1) 2009: the role of adipokines in the modulation of respiratory defenses]H Salvator, P Devillier, E Rivaud, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1992
Activation of an epithelial neurokinin NK-1 receptor induces relaxation of rat trachea through release of prostaglandin E2P Devillier, G M Acker, C Advenier, et al.
Revue Des Maladies Respiratoires|November 14, 2014
[A new fixed dose combination of fluticasone and formoterol in a pressurised metered-dose inhaler for the treatment of asthma]P Devillier, H Salvator, S Grassin-Delyle, et al.
Allergy|July 25, 2014
House dust mite sublingual immunotherapy is safe and appears to be effective in moderate, persistent asthmaL Wang, J Yin, R Fadel, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 8, 2010
Pharmacological characterization of olodaterol, a novel inhaled beta2-adrenoceptor agonist exerting a 24-hour-long duration of action in preclinical modelsT Bouyssou, P Casarosa, E Naline, et al.
Cardiovascular Research|December 21, 2000
Cysteinyl leukotrienes are involved in angiotensin II-induced contraction of aorta from spontaneously hypertensive ratsF Stanke-Labesque, P Devillier, S Veitl, et al.
British Journal of Clinical Pharmacology|December 23, 1998
Frusemide inhibits angiotensin II-induced contraction on human vascular smooth muscleF Stanke, P Devillier, D Bréant, et al.
Fundamental & Clinical Pharmacology|January 1, 1997
Pharmacokinetics of intrarectal nalbuphine in children undergoing general anaesthesiaG Bessard, J P Alibeu, M Cartal, et al.
Pageof 15